Feasibility of IA Thrombolysis for Acute Ischemic Stroke Among Anticoagulated Patients
- 1 August 2007
- journal article
- case report
- Published by Springer Nature in Neurocritical Care
- Vol. 7 (2), 152-155
- https://doi.org/10.1007/s12028-007-0027-7
Abstract
Limited information exists regarding thrombolysis among anticoagulated acute stroke patients. We present data from three consecutive patients, on active warfarin therapy, treated with intra-arterial reteplase.Keywords
This publication has 11 references indexed in Scilit:
- Middle Cerebral Arterial Thrombosis in a Patient with Hypofibrinogenemia, 5 Days After rFVIIa and FFP InfusionClinical and Applied Thrombosis/hemostasis, 2006
- Thrombolysis (different doses, routes of administration and agents) for acute ischaemic strokePublished by Wiley ,2004
- Impaired Warfarin Response Secondary to High-Dose Vitamin K1for Rapid Anticoagulation Reversal: Case Series and Literature ReviewPharmacotherapy: The Journal of Human Pharmacology and Drug Therapy, 2004
- Treatment of Warfarin-Associated CoagulopathyChest, 2001
- Cerebral hemorrhage after intra-arterial thrombolysis for ischemic strokeNeurology, 2001
- Risk Factors for Severe Hemorrhagic Transformation in Ischemic Stroke Patients Treated With Recombinant Tissue Plasminogen ActivatorStroke, 2001
- Intra-arterial Prourokinase for Acute Ischemic StrokeJAMA, 1999
- PROACT: A Phase II Randomized Trial of Recombinant Pro-Urokinase by Direct Arterial Delivery in Acute Middle Cerebral Artery StrokeStroke, 1998
- Guidelines for Thrombolytic Therapy for Acute Stroke: A Supplement to the Guidelines for the Management of Patients With Acute Ischemic StrokeCirculation, 1996
- Tissue Plasminogen Activator for Acute Ischemic StrokeNew England Journal of Medicine, 1995